A phase 1 study to evaluate the feasibility and efficacy of the addition of ropeginterferon alpha‐2b to imatinib treatment in patients with chronic phase chronic myeloid leukemia (CML) not achieving…

Overview of attention for article published in Hematological Oncology, August 2020

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (51st percentile)

Mentioned by

twitter: 2 X users
peer_reviews: 1 peer review site

facebook: 2 Facebook pages

Citations

dimensions_citation: 8 Dimensions

Readers on

mendeley: 14 Mendeley

Summary X Peer reviews Facebook Dimensions citations

So far, Altmetric has seen 2 public wall posts from 2 users.

MPN, 10 Sep 2020

The goal of current management of patients with chronic phase chronic myeloid leukemia (CML) is to reach treatment‐free…

PV Reporter, 10 Sep 2020

👉 As a PV patient, I have 5+ years experience on combination therapy with Pegasys (interferon) and Ruxolitinib (Jakafi). I…

This page shows the most recent Facebook posts that mention this research output.

Click here to find out how to access more activity.